PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiothoracic Surgery, Lihuili Hospital affiliated to Ningbo University, Ningbo, Zhejiang 315041, China; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.\', \'Department of Cardiothoracic Surgery, Lihuili Hospital affiliated to Ningbo University, Ningbo, Zhejiang 315041, China.\', \'Department of Cardiothoracic Surgery, Lihuili Hospital affiliated to Ningbo University, Ningbo, Zhejiang 315041, China. Electronic address: sgf1958@sina.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1873-5061(21)00014-310.1016/j.scr.2021.102168
?:hasPublicationType
?:journal
  • Stem cell research
is ?:pmid of
?:pmid
?:pmid
  • 33485182
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.214
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all